| Literature DB >> 35628556 |
Abstract
Unrelated genetic mutations can lead to convergent manifestations of neurological disorders with similar behavioral phenotypes. Experimental data frequently show a lack of dramatic changes in neuroanatomy, indicating that the key cause of symptoms might arise from impairment in the communication between neurons. A transient imbalance between excitatory (glutamatergic) and inhibitory (GABAergic) synaptic transmission (the E/I balance) during early development is generally considered to underlie the development of several neurological disorders in adults. However, the E/I ratio is a multidimensional variable. Synaptic contacts are highly dynamic and the actual strength of synaptic projections is determined from the balance between synaptogenesis and synaptic elimination. During development, relatively slow postsynaptic receptors are replaced by fast ones that allow for fast stimulus-locked excitation/inhibition. Using the binomial model of synaptic transmission allows for the reassessing of experimental data from different mouse models, showing that a transient E/I shift is frequently counterbalanced by additional pre- and/or postsynaptic changes. Such changes-for instance, the slowing down of postsynaptic currents by means of immature postsynaptic receptors-stabilize the average synaptic strength, but impair the timing of information flow. Compensatory processes and/or astrocytic signaling may represent possible targets for medical treatments of different disorders directed to rescue the proper information processing.Entities:
Keywords: binomial model of synaptic transmission; genetic mouse models; neurological disorders; quantal size; readily releasable pool; release probability
Mesh:
Year: 2022 PMID: 35628556 PMCID: PMC9145842 DOI: 10.3390/ijms23105746
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1General mechanisms that determine the strength of synaptic transmission. (A) Number of synaptic contacts visualized immunohistochemically is frequently taken as an estimate of the strength of synaptic excitatory/inhibitory inputs. (B) Functional strength of synaptic drive in the frame of binomial model of synaptic transmission is determined presynaptically by RRP, the readily releasable pool of vesicles, and release probability, and postsynaptically by the quantal size, the amplitude of postsynaptic response to release of a single vesicle, and its kinetics (charge). Miniature postsynaptic currents (mPSCs), i.e., synaptic responses measured in the presence of tetrodotoxin, a blocker of voltage-gated Na+ channels, are often used as a quantal size estimate. Note that the RRP size is not a constant and depends of the rate of vesicle recycling, RRP refilling rate.
Figure 2Possible mechanisms operating to correct the E/I imbalance but leading to a distorted timing of synaptic transmission. (A) Presynaptically, reduced RRP size may be counterbalanced by faster vesicle recycling rate, red arrows, supporting proper synaptic function during periods of activity (Mecp2-KO and FMR1-KO). Note a temporal jitter of postsynaptic responses at KO synapses. (B) Postsynaptically, reduced number of postsynaptic receptors, a smaller quantal size, is compensated for by involvement of slower postsynaptic receptors, stabilizing, in turn, the quantal charge (FMR1-, Nlg4-, and DTNBP1-KO). (C) Astrocytic ionic signaling induced by neuronal activity leads to spatially heterogeneous release of gliotransmitters and/or changes in neurotransmitter uptake rate (Nlg4-KO).
Changes in glutamatergic and GABAergic transmission observed in the mouse models. Empty boxes mean “no data reported”. Note that both mean amplitude and area of mPSCs (if reported) are mentioned in the column “Quantal size”.
| Mouse Model | Excitation/ | RRP | Pv | Quantal Size | RRP Refilling | References |
|---|---|---|---|---|---|---|
| FMP1-KO | Glutamate | Increased | Not changed | Not changed | Accelerated | [ |
| GABA | Increased | Not changed | Charge increased | [ | ||
| Nlgn-4-KO | Glutamate | Reduced | Reduced | Not changed | [ | |
| GABA | Reduced | Reduced | Charge increased | [ | ||
| Mecp2-KO | Glutamate | Not changed | Not changed | Reduced | [ | |
| GABA | Not changed | Not changed | Amplitude—increased, Charge —reduced | Accelerated | [ | |
| Ophn1-KO | Glutamate | Increased | Not changed | Slowed | [ | |
| GABA | Reduced | Increased | Not changed | Accelerated | [ | |
| DTNBP1-KO | Glutamate | Reduced | Increased | Amplitude—not changed, | Not changed | [ |
| GABA | Increased | Amplitude—decreased, | [ |